A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
Clinical trial NCT00559117 · UNKNOWN
Trial details
- NCT number
- NCT00559117
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.